生命科学领域人工智慧市场：按产品、分析方法、应用、最终用户、实行技术、分销管道和区域划分

预计到 2025 年，生命科学领域的人工智慧市场规模将达到 37.3 亿美元，到 2032 年将达到 180.9 亿美元，2025 年至 2032 年的复合年增长率为 25.3%。

全球生命科学人工智慧市场代表着尖端运算技术与生物学研究的变革性融合，它从根本上重塑了製药公司、生物技术公司和研究机构进行药物研发、临床试验和患者照护的方式。这个充满活力的市场涵盖了机器学习演算法、自然语言处理、电脑视觉和预测分析等技术的应用，旨在加速基因组学、蛋白质组学、药物研发和个人化医疗等领域的科学突破。

人工智慧技术正在革新传统的生命科学研究方法，使研究人员能够以前所未有的精确度和速度分析大量资料集、识别新的药物标靶、优化临床试验调查方法并预测治疗结果。生物数据的指数级增长、计算能力的不断提升以及降低新治疗方法上市时间和成本的迫切需求，共同推动了人工智慧在生命科学领域的应用。从分子化合物的虚拟筛检到人工智慧驱动的诊断工具，再到机器人实验室自动化，这些技术正在建构科学发现和医疗服务的新范式，并将人工智慧定位为现代生命科学生态系统创新不可或缺的催化剂。

市场动态

全球生命科学领域的人工智慧市场由几个关键驱动因素推动，这些因素正在从根本上改变产业格局。生物数据（包括基因组序列数据、临床记录和生物标记资讯）的指数级增长，催生了对能够处理复杂数据集并从中提取有意义见解的先进人工智慧演算法的需求。传统药物研发流程成本不断攀升且耗时过长（可能耗资超过26亿美元，耗时10-15年），促使製药公司采用人工智慧解决方案，以大幅缩短新疗法上市的时间和降低财务负担。此外，对个人化医疗和精准治疗的日益重视，也催生了对能够分析患者特定数据并优化治疗通讯协定的人工智慧工具的巨大需求。

然而，该市场也面临着许多限制，包括严格的法规结构要求在临床应用前对人工智慧演算法进行广泛的检验、与处理患者资讯相关的数据隐私问题，以及能够有效弥合人工智慧技术与生命科学应用之间差距的熟练专业人员短缺。

此外，部署人工智慧基础设施的高昂初始投资成本以及将人工智慧系统整合到现有实验室和临床工作流程中的难度，对规模较小的机构构成了重大障碍。儘管存在这些挑战，但市场也蕴藏着巨大的机会，这得益于创业投资对人工智慧驱动的生命科学Start-Ups的投资不断增加、科技巨头与製药公司之间合作日益密切、人工智慧在医学影像和病理学等领域的应用不断扩展，以及云端基础人工智慧平台的加速普及——这些平台使各种规模的机构都能获得先进的运算能力。

本报告的主要特点

• 本报告对全球生命科学领域的人工智慧市场进行了详细分析，以 2024 年为基准年，对预测期（2025-2032 年）的市场规模和复合年增长率进行了预测。
• 它还重点介绍了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的关键见解。
• 根据公司概况、产品系列、主要亮点、财务表现和策略等参数，对全球生命科学人工智慧市场的主要企业进行了分析。
• 本报告提供的见解将使负责人和企业经营团队能够就未来的产品发布、合作关係、市场扩张和行销策略做出明智的决策。
• 《全球生命科学人工智慧市场》报告面向该产业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过各种策略矩阵来分析全球生命科学人工智慧市场，从而更轻鬆地做出决策。

目录

第一章 分析目标与先决条件

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章：市场动态、监理及趋势分析

• 市场动态
• 司机
• 抑制因素
• 机会
• 影响分析
• 重大进展
• 监管情景
• 产品上市/核准
• PEST分析
• 波特五力分析
• 企业合併情景
• 产业趋势

4. 全球生命科学领域人工智慧市场（按产品/服务划分）（2020-2032 年）

• 介绍
• 软体（演算法、人工智慧平台、模组等）
• 硬体（计算基础设施、专用感测器、成像设备等）
• 服务（咨询、整合、培训、维护等）

5. 全球生命科学领域人工智慧市场以部署方式划分（2020-2032 年）

• 介绍
• 云端基础的
• 本地部署

6. 全球生命科学领域人工智慧市场分析方法（2020-2032 年）

• 介绍
• 说明/报告性
• 预测
• 指导性/决策支援
• 生成/合成数据/人工智慧驱动的分子生成

7. 全球生命科学领域人工智慧市场（按应用领域划分）（2020-2032 年）

• 介绍
• 药物发现与开发
• 临床试验设计与优化
• 医学诊断、影像诊断/生物标记检测
• 精准医疗，个人化医疗
• 生物技术/生物製程/体学
• 病患监测，真实世界证据（RWE）
• 监管/安全和药物警戒

8. 全球生命科学领域人工智慧市场（按最终用户划分）（2020-2032 年）

• 介绍
• 製药和生物技术公司
• 委外研发机构/临床开发公司
• 医疗设备製造商
• 学术研究机构
• 医疗机构（医院/诊所）
• 监管机构和安全委员会

9. 全球生命科学领域人工智慧市场（实行技术划分）（2020-2032 年）

• 介绍
• 机器学习/统计模型
• 自然语言处理（NLP）/文字探勘
• 医疗设备製造商
• 电脑视觉/影像人工智慧
• 深度学习/神经网络
• 混合多模态人工智慧（模态融合）

10. 全球生命科学领域人工智慧市场按通路划分（2020-2032 年）

• 介绍
• 医院药房
• 零售药房
• 网路药房

第十一章 全球生命科学领域人工智慧市场（按地区划分）（2020-2032 年）

• 介绍
• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中非

第十二章 竞争格局

• Insilico Medicine
• Atomwise
• Exscientia
• Schrodinger
• Recursion Pharmaceuticals
• BenevolentAI
• Cyclica
• Iktos
• Owkin
• Evogene
• Anima Biotech
• Generate Biomedicines
• Nimbus Therapeutics
• DeepMind/Isomorphic Labs
• IBM Watson Health

第十三章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map (COM)

第十四章 参考文献与分析方法

• 参考
• 分析方法
• 关于 Coherent Market Insights

Artificial Intelligence in Life Science Market is estimated to be valued at USD 3.73 Bn in 2025 and is expected to reach USD 18.09 Bn by 2032, growing at a compound annual growth rate (CAGR) of 25.3% from 2025 to 2032.

The global artificial intelligence in life science market represents a transformative convergence of cutting-edge computational technologies and biological research, fundamentally reshaping how pharmaceutical companies, biotechnology firms, and research institutions approach drug discovery, clinical trials, and patient care. This dynamic market encompasses the application of machine learning algorithms, natural language processing, computer vision, and predictive analytics to accelerate scientific breakthroughs in areas such as genomics, proteomics, drug development, and personalized medicine.

AI technologies are revolutionizing traditional life science methodologies by enabling researchers to analyze vast datasets, identify novel drug targets, optimize clinical trial designs, and predict treatment outcomes with unprecedented accuracy and speed. The integration of AI in life sciences is driven by the exponential growth of biological data, increasing computational power, and the urgent need to reduce the time and cost associated with bringing new therapies to market. From virtual screening of molecular compounds to AI-powered diagnostic tools and robotic laboratory automation, these technologies are creating new paradigms for scientific discovery and healthcare delivery, positioning artificial intelligence as an indispensable catalyst for innovation in the modern life sciences ecosystem.

Market Dynamics

The global artificial intelligence in life science market is propelled by several key drivers that are fundamentally transforming the industry landscape. The exponential increase in biological data generation, including genomic sequencing data, clinical records, and biomarker information, necessitates sophisticated AI algorithms capable of processing and extracting meaningful insights from complex datasets. The rising costs and extended timelines associated with traditional drug development processes, which can exceed USD 2.6 billion and span 10-15 years, are driving pharmaceutical companies to adopt AI solutions that can significantly reduce both financial burden and time-to-market for new therapeutics. Additionally, the growing emphasis on personalized medicine and precision therapeutics is creating substantial demand for AI-powered tools that can analyze patient-specific data to optimize treatment protocols.

However, the market faces notable restraints including stringent regulatory frameworks that require extensive validation of AI algorithms before clinical implementation, data privacy concerns related to patient information handling, and the shortage of skilled professionals who can effectively bridge the gap between AI technology and life science applications.

Furthermore, the high initial investment costs for implementing AI infrastructure and the challenge of integrating AI systems with existing laboratory and clinical workflows present significant barriers for smaller organizations. Despite these challenges, the market presents tremendous opportunities driven by increasing venture capital investments in AI-driven life science startups, growing collaborations between technology giants and pharmaceutical companies, expanding applications in areas such as medical imaging and diagnostic pathology, and the accelerating adoption of cloud-based AI platforms that democratize access to advanced computational capabilities across organizations of all sizes.

Key Features of the Study

• This report provides in-depth analysis of the global artificial intelligence in life science market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global artificial intelligence in life science market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Insilico Medicine, Atomwise, Exscientia, Schrodinger, Recursion Pharmaceuticals, BenevolentAI, Cyclica, Iktos, Owkin, Evogene, Anima Biotech, Generate Biomedicines, Nimbus Therapeutics, DeepMind/Isomorphic Labs, and IBM Watson Health
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global artificial intelligence in life science market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in life science market

Market Segmentation

• Offering Insights (Revenue, USD Bn, 2020 - 2032)
  • Software (algorithms, AI-powered platforms, modules, etc.)
  • Hardware (compute infrastructure, specialized sensors, imaging devices, etc.)
  • Services (consulting, integration, training, maintenance, etc.)
• Deployment Model Insights (Revenue, USD Bn, 2020 - 2032)
  • Cloud Based
  • On-premise
• Analytics Insights (Revenue, USD Bn, 2020 - 2032)
  • Descriptive/Reporting
  • Predictive
  • Prescriptive/Decision support
  • Generative/Synthetic data/AI-driven molecule generation
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Drug Discovery and Development
  • Clinical Trials Design and Optimization
  • Medical Diagnosis and Imaging/Biomarker Detection
  • Precision and Personalized Medicine
  • Biotechnology/Bioprocessing/Omics
  • Patient Monitoring and Real-World Evidence (RWE)
  • Regulatory/Safety and Pharmacovigilance
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)/Clinical Research Firms
  • Medical Device Manufacturers
  • Academic and Research Institutions
  • Healthcare Providers (Hospitals/Diagnostic Clinics)
  • Regulatory Agencies and Safety Boards
• Enabling Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • Machine Learning/Statistical Models
  • Natural Language Processing (NLP)/Text Mining
  • Computer Vision/Imaging AI
  • Deep Learning/Neural Networks
  • Hybrid and Multi-modal AI(fusion of modalities)
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Insilico Medicine
  • Atomwise
  • Exscientia
  • Schrodinger
  • Recursion Pharmaceuticals
  • BenevolentAI
  • Cyclica
  • Iktos
  • Owkin
  • Evogene
  • Anima Biotech
  • Generate Biomedicines
  • Nimbus Therapeutics
  • DeepMind/Isomorphic Labs
  • IBM Watson Health

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Artificial Intelligence in Life Science Market, By Offering
  • Global Artificial Intelligence in Life Science Market, By Deployment Model
  • Global Artificial Intelligence in Life Science Market, By Analytics
  • Global Artificial Intelligence in Life Science Market, By Application
  • Global Artificial Intelligence in Life Science Market, By End User
  • Global Artificial Intelligence in Life Science Market, By Enabling Technology
  • Global Artificial Intelligence in Life Science Market, By Distribution Channel
  • Global Artificial Intelligence in Life Science Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Artificial Intelligence in Life Science Market, By Offering, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Software (algorithms, AI-powered platforms, modules, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hardware (compute infrastructure, specialized sensors, imaging devices, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Services (consulting, integration, training, maintenance, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Artificial Intelligence in Life Science Market, By Deployment Model, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cloud Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• On-premise
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Artificial Intelligence in Life Science Market, By Analytics, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Descriptive/Reporting
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Predictive
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Prescriptive/Decision support
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Generative/Synthetic data/AI-driven molecule generation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Artificial Intelligence in Life Science Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Drug Discovery and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Clinical Trials Design and Optimization
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Medical Diagnosis and Imaging/Biomarker Detection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Precision and Personalized Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Biotechnology/Bioprocessing/Omics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Patient Monitoring and Real-World Evidence (RWE)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Regulatory/Safety and Pharmacovigilance
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Artificial Intelligence in Life Science Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organizations (CROs)/Clinical Research Firms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Medical Device Manufacturers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Healthcare Providers (Hospitals/Diagnostic Clinics)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Regulatory Agencies and Safety Boards
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Artificial Intelligence in Life Science Market, By Enabling Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Machine Learning/Statistical Models
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Natural Language Processing (NLP)/Text Mining
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Medical Device Manufacturers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Computer Vision/Imaging AI
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Deep Learning/Neural Networks
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hybrid and Multi-modal AI(fusion of modalities)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Artificial Intelligence in Life Science Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Artificial Intelligence in Life Science Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Offering, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Deployment Model, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Analytics, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Enabling Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

12. Competitive landscape

• Insilico Medicine
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Atomwise
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Exscientia
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Schrodinger
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Recursion Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BenevolentAI
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cyclica
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Iktos
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Owkin
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Evogene
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Anima Biotech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Generate Biomedicines
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nimbus Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DeepMind/Isomorphic Labs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• IBM Watson Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

13. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

14. References and Research Methodology

• References
• Research Methodology
• About Us